Mechanism
CEACAM5/CEACAM6 (tumor-associated variants)
Assets acting on this target.
- Class
- Humanized IgG1 monoclonal antibody
- Pathway
- Antibody-dependent cellular cytotoxicity (ADCC) against CEACAM5/6-expressing tumor cells
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.